← Leaderboards
Timothy Sebastian Pardee
Wake Forest University Health Sciences
$4,288,289
Attributed
$5,583,658
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $877.3K · FY2012–25$1M$750K$500K$250K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,583,658 · 5
By mechanism
R01$1,762,177 · 1
T32$1,409,113 · 1
U01$1,181,625 · 1
K08$839,900 · 1
R21$390,843 · 1
Top collaborators
- Kounosuke Watabe5 shared
- Keith D Bonin2 shared
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Edward G Shaw$22,365,759
- Nancy E Avis$9,658,718
- Edward A Levine$1,866,520
- Isabelle M Berquin$1,923,047
- Ralph B. Dagostino$15,515,654
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsCellsResponseMitochondriaCell LineResistanceSourceTraining ProgramsNovel StrategiesFatty AcidsNeoplastic CellOncologyEnzymesFatty Acid OxidationAerobicIn VitroMetabolicCell SurvivalFatty-Acid SynthaseCitric Acid CycleChemotherapyIn VivoDna DamageAnaerobic Glycolysis
Grant awards (19)
Developing Acute Myeloid Leukemia Models with Diverse Ancestral Origins$177,249
R21 · FY2025 · CA · contact PI
Translational Oncology Training Program$266,711
T32 · FY2024 · CA
Developing Acute Myeloid Leukemia Models with Diverse Ancestral Origins$213,594
R21 · FY2024 · CA · contact PI
Translational Oncology Training Program$320,060
T32 · FY2023 · CA
Chromatin mobility in response to DNA damage$580,321
U01 · FY2022 · CA · contact PI
Translational Oncology Training Program$279,234
T32 · FY2022 · CA
Chromatin mobility in response to DNA damage$601,304
U01 · FY2021 · CA · contact PI
Translational Oncology Training Program$276,006
T32 · FY2021 · CA
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia$354,563
R01 · FY2020 · CA · contact PI
Translational Oncology Training Program$267,102
T32 · FY2020 · CA
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia$343,925
R01 · FY2019 · CA · contact PI
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia$354,563
R01 · FY2018 · CA · contact PI
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia$354,563
R01 · FY2017 · CA · contact PI
Determining the Role of Metabolism in Resistance in Acute Myeloid Leukemia$354,563
R01 · FY2016 · CA · contact PI
Metabolic contribution to cell viability and therapy resistance in the acute$167,980
K08 · FY2016 · CA · contact PI
Metabolic contribution to cell viability and therapy resistance in the acute$167,980
K08 · FY2015 · CA · contact PI
Metabolic contribution to cell viability and therapy resistance in the acute$167,980
K08 · FY2014 · CA · contact PI
Metabolic contribution to cell viability and therapy resistance in the acute$167,980
K08 · FY2013 · CA · contact PI
Metabolic contribution to cell viability and therapy resistance in the acute$167,980
K08 · FY2012 · CA · contact PI